Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Leggett & Platt (NY:LEG)

7.490 +0.650 (+9.50%)
Official Closing Price Updated: 7:00 PM EDT, Apr 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Leggett & Platt

< Previous 1 2 3 4 5 6 7 8 Next >
Dividend Income Update April 2023
With May already underway it is time for all dividend income investors to look back at the previous month and see how much passive dividend income their portfolios generated. 
Via Talk Markets
Check Out 3 Consumer Stocks With Over 5% Dividend Yields From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Leggett & Platt Announces 1Q 2023 Earnings Call
From Leggett & Platt, Incorporated
Via GlobeNewswire
Goldman Sachs Downgrades Leggett & Platt: Here's What You Need To Know
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2023
Via Benzinga
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
Earnings Preview: Leggett & Platt
Via Benzinga
Tuesday Talk: April Flowers
So far it's April flowers as stocks continued upwards on Monday, with the announced OPEC+ production cut creating a rally in Oil related issues. 
Via Talk Markets
April 2023 Stock Considerations
Let’s take a look at my April stock considerations which are similar to recent considerations from one to four months ago. 
Via Talk Markets
Recent Stock Purchases For March 2023
As readers may know by now, I make stock purchases every single month, no matter what is going on in the world. This month, I went heavier than I normally do, deploying over $3,000. Let's take a look. 
Via Talk Markets
Could Tempur Sealy be the Sleeper Stock of 2023?
Bedding products manufacturer Tempur Sealy International Inc. (NYSE: TPX) stock has been quietly rising towards all-time highs. The world's largest bedding 
Via MarketBeat
Dividend Income Update For January 2023
Without rehashing the wild ride we experienced in the market over the last few months, I could find comfort in one thing: my dividends (even if dividend cuts are on the table these days). Let's see how... 
Via Talk Markets
Leggett & Platt's Earnings Outlook
Via Benzinga
Why Bed Bath & Beyond Fell Almost 30%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
Earnings Scheduled For February 6, 2023
Companies Reporting Before The Bell • Cummins (NYSE:CMI) is projected to report quarterly earnings at $4.56 per share on revenue of $7.21 billion. 
Via Benzinga
Leggett & Platt Announces 4Q 2022 Earnings Call
From Leggett & Platt, Incorporated
Via GlobeNewswire
3 Worst Performing Dividend Aristocrats In 2022
The year 2022 proved difficult to traverse for investors. But the dividend growth investing strategy performed reasonably well, in many cases. 
Via Talk Markets
3 Worst Performing Dividend Kings In 2022
A look at the three worst-performing Dividend Kings in 2022 which are Stanley Black & Decker, Target, and 3M Company. 
Via Talk Markets
Leggett & Platt's Debt Overview
Shares of Leggett & Platt Inc. (NYSE:LEG) decreased by 2.17% in the past three months. Before having a look at the importance of debt, let's look at how much debt Leggett & Platt has. 
Via Benzinga
Reliable Passive Income: an Analysis on Dividend Kings
A Dividend King is any stock that has increased its dividend for 50+ cosecutive years, doubling that of a Dividend Aristocrat. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 12, 2022
Via Benzinga
Top 20 Highest-Yielding Dividend Aristocrats Now, Yields Up To 6.3%
20 Dividend Aristocrats that have market-beating dividend yields. They also have high-quality business models, durable competitive advantages, and long-term growth potential. 
Via Talk Markets
Current Report: Leggett & Platt
By my dogcatcher ideal, this is probably a good time to buy Leggett & Platt Inc shares based on their dividends for the coming year 2022-23. 
Via Talk Markets
Dividend Income Update October 2022
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio. 
Via Talk Markets
Earnings Scheduled For October 31, 2022
Companies Reporting Before The Bell • Insperity (NYSE:NSP) is estimated to report quarterly earnings at $0.96 per share on revenue of $1.46 billion. 
Via Benzinga
Leggett & Platt's Earnings: A Preview
Leggett & Platt (NYSE:LEG) is set to give its latest quarterly earnings report on Monday, 2022-10-31. Here's what investors need to know before the announcement. Analysts estimate that Leggett & Platt... 
Via Benzinga
Don’t Overlook These 10 High Yield Dividend Champions
High-yield Dividend Champions are attractive to income investors, not just for their high yields, but also for their long track records of growing their dividends. 
Via Talk Markets
Leggett & Platt Announces 3Q 2022 Earnings Call
From Leggett & Platt, Incorporated
Via GlobeNewswire
Uber, Lyft, AZZ And Other Big Losers From Tuesday
U.S. stocks closed mixed with the Nasdaq Composite dropping more than 100 points on Tuesday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.